- Home
- CYBN vs PLL Comparison
CYBN vs PLL Comparison
Compare CYBN & PLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- PLL
- Stock Information
- Founded
- CYBN 2019
- PLL 2016
- Country
- CYBN Canada
- PLL United States
- Employees
- CYBN N/A
- PLL N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- PLL Other Metals and Minerals
- Sector
- CYBN Health Care
- PLL Basic Materials
- Exchange
- CYBN Nasdaq
- PLL Nasdaq
- Market Cap
- CYBN 176.5M
- PLL 184.1M
- IPO Year
- CYBN N/A
- PLL 2017
- Fundamental
- Price
- CYBN $6.08
- PLL N/A
- Analyst Decision
- CYBN Strong Buy
- PLL Hold
- Analyst Count
- CYBN 3
- PLL 5
- Target Price
- CYBN $85.00
- PLL $10.31
- AVG Volume (30 Days)
- CYBN 621.7K
- PLL 690.8K
- Earning Date
- CYBN 11-12-2025
- PLL 08-07-2025
- Dividend Yield
- CYBN N/A
- PLL N/A
- EPS Growth
- CYBN N/A
- PLL N/A
- EPS
- CYBN N/A
- PLL N/A
- Revenue
- CYBN N/A
- PLL $105,102,000.00
- Revenue This Year
- CYBN N/A
- PLL N/A
- Revenue Next Year
- CYBN N/A
- PLL $33.37
- P/E Ratio
- CYBN N/A
- PLL N/A
- Revenue Growth
- CYBN N/A
- PLL 58.18
- 52 Week Low
- CYBN $4.81
- PLL $5.15
- 52 Week High
- CYBN $13.88
- PLL $15.44
- Technical
- Relative Strength Index (RSI)
- CYBN 38.92
- PLL 14.27
- Support Level
- CYBN $6.16
- PLL $8.48
- Resistance Level
- CYBN $6.55
- PLL $9.43
- Average True Range (ATR)
- CYBN 0.49
- PLL 0.25
- MACD
- CYBN -0.06
- PLL -0.73
- Stochastic Oscillator
- CYBN 12.90
- PLL 0.00
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About PLL Piedmont Lithium Inc.
Piedmont Lithium Inc, is a U.S. based, development-stage, multi-asset, integrated lithium business in support of a clean energy economy and U.S. and world-wide energy security. Its portfolio of wholly-owned projects includes Carolina Lithium, a proposed fully integrated spodumene ore-to-lithium hydroxide project in Gaston County, North Carolina, and Tennessee Lithium, a proposed merchant lithium hydroxide manufacturing plant in McMinn County, Tennessee.